49 related articles for article (PubMed ID: 21584284)
1. Fusion proteins comprising annexin V and Kunitz protease inhibitors are highly potent thrombogenic site-directed anticoagulants.
Chen HH; Vicente CP; He L; Tollefsen DM; Wun TC
Blood; 2005 May; 105(10):3902-9. PubMed ID: 15677561
[TBL] [Abstract][Full Text] [Related]
2. Annexin A5-conjugated polymeric micelles for dual SPECT and optical detection of apoptosis.
Zhang R; Lu W; Wen X; Huang M; Zhou M; Liang D; Li C
J Nucl Med; 2011 Jun; 52(6):958-64. PubMed ID: 21571801
[TBL] [Abstract][Full Text] [Related]
3. Annexin-V promotes anti-tumor immunity and inhibits neuroblastoma growth in vivo.
Yan X; Doffek K; Yin C; Krein M; Phillips M; Sugg SL; Johnson B; Shilyansky J
Cancer Immunol Immunother; 2012 Nov; 61(11):1917-27. PubMed ID: 22476407
[TBL] [Abstract][Full Text] [Related]
4. Molecular Sensing and Manipulation of Protein Oligomerization in Membrane Nanotubes with Bolaamphiphilic Foldamers.
Aftahy K; Arrasate P; Bashkirov PV; Kuzmin PI; Maurizot V; Huc I; Frolov VA
J Am Chem Soc; 2023 Nov; 145(46):25150-25159. PubMed ID: 37948300
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Novel Anti-thrombotic Fusion Proteins for Inhibition of Stenosis in a Porcine Model of Arteriovenous Graft.
Terry CM; Zhuplatov I; He Y; Wun TC; Kim SE; Cheung AK
PLoS One; 2015; 10(9):e0137381. PubMed ID: 26360605
[TBL] [Abstract][Full Text] [Related]
6. Targeting phosphatidylserine for radionuclide-based molecular imaging of apoptosis.
Wuest M; Perreault A; Richter S; Knight JC; Wuest F
Apoptosis; 2019 Apr; 24(3-4):221-244. PubMed ID: 30684144
[TBL] [Abstract][Full Text] [Related]
7. Monitoring apoptosis in real time.
Green AM; Steinmetz ND
Cancer J; 2002; 8(2):82-92. PubMed ID: 11999952
[TBL] [Abstract][Full Text] [Related]
8. Investigation of a potential scintigraphic tracer for imaging apoptosis: radioiodinated annexin V-Kunitz protease inhibitor fusion protein.
Liao MH; Jan TR; Chiang CC; Yen KC; Liao TZ; Chen MW; Chi CW; Wun TC; Yen TC; Wey SP
J Biomed Biotechnol; 2011; 2011():675701. PubMed ID: 21584284
[TBL] [Abstract][Full Text] [Related]
9. Potent cardioprotection from ischemia-reperfusion injury by a two-domain fusion protein comprising annexin V and Kunitz protease inhibitor.
Yeh CH; Chen TP; Wang YC; Fang SW; Wun TC
J Thromb Haemost; 2013 Aug; 11(8):1454-63. PubMed ID: 23746209
[TBL] [Abstract][Full Text] [Related]
10. Novel Injury Site Targeted Fusion Protein Comprising Annexin V and Kunitz Inhibitor Domains Ameliorates Ischemia-Reperfusion Injury and Promotes Survival of Ischemic Rat Abdominal Skin Flaps.
Shyu VB; Hsu CE; Wen CJ; Wun TC; Tang R; Achilefu S; Wei FC; Cheng HY
Ann Plast Surg; 2017 Mar; 78(3 Suppl 2):S129-S134. PubMed ID: 28166139
[TBL] [Abstract][Full Text] [Related]
11. Bolus injections of novel thrombogenic site-targeted fusion proteins comprising annexin-V and Kunitz protease inhibitors attenuate intimal hyperplasia after balloon angioplasty.
Yeh YH; Chang SH; Chen SY; Wen CJ; Wei FC; Tang R; Achilefu S; Wun TC; Chen WJ
Int J Cardiol; 2017 Aug; 240():339-346. PubMed ID: 28433556
[TBL] [Abstract][Full Text] [Related]
12. Measurement of the binding parameters of annexin derivative-erythrocyte membrane interactions.
Yen TC; Wey SP; Liao CH; Yeh CH; Shen DW; Achilefu S; Wun TC
Anal Biochem; 2010 Nov; 406(1):70-9. PubMed ID: 20599633
[TBL] [Abstract][Full Text] [Related]
13. Passivating Injured Endothelium with Kinexins in Thrombolytic Therapy.
Ma YH; Huang CW; Wen CJ; Lu YC; Wey SP; Wun TC
Thromb Haemost; 2018 Jan; 118(1):90-102. PubMed ID: 29304529
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
